Annovis Bio (ANVS)
(Delayed Data from NYSE)
$2.51 USD
-0.22 (-8.06%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.49 -0.02 (-0.80%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Annovis Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANVS 2.51 -0.22(-8.06%)
Will ANVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ANVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANVS
All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy
Amicus (FOLD) Up as Q2 Earnings & Sales Top, '24 View Updated
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat
Catalyst (CPRX) Rises as Q2 Earnings & Revenues Beat Estimates
Other News for ANVS
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket
Annovis Bio’s Promising Alzheimer’s Study: A Potential Game Changer?
12 Health Care Stocks Moving In Wednesday's Intraday Session
Annovis Bio (ANVS) Stock Jumps Over 16% in Market Trading | ANVS Stock News
Annovis Bio rises 16.3%